bullish
Burning Rock (传奇生物) IPO: Sentiment Matters
331 Views08 Jun 2020 14:49
Burning Rock, a leading precision oncology player in China, started book building to raise up to USD 235 million (including concurrent private...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- Burning Rock Biotech (BNR US): Attractive Growth Story Outshined by Surging COVID Cases in China31 Mar 2022
- Burning Rock Biotech (BNR US): Muted Near-Term Outlook on Resurgence of COVID-19 in China07 Nov 2021
- Burning Rock (燃石医学) IPO Trading: Hot Deal, Small Float12 Jun 2020
- Burning Rock (传奇生物) IPO: Sentiment Matters08 Jun 2020
- Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation04 Jun 2020
- Burning Rock (燃石医学) Pre-IPO: Leading Precision Oncology Player but Short of Disclosure29 May 2020
x